Nuclear Liabilities Fund to invest £250m in innovative companies

British Patient Capital, part of the Government-backed British Business Bank, will manage £250 million on behalf of the NLF, investing in venture and growth capital funds, targeting investment in high potential innovative companies across the UK.

The investment supports the primary objective of the NLF, which is a UK Government fund set-up in 1996, to provide arrangements for funding certain long-term costs for the decommissioning of eight nuclear power stations formerly owned by British Energy, now EDF Energy.

40% of Europe’s artificial intelligence start-ups found to lack AI

While the hype around AI continues to attract large funding, a survey has highlighted that many of Europe’s “AI-start-ups” do not actually use it

“We are pleased to be working with British Patient Capital on diversifying our portfolio. As a matter of principle, we look to hold a significant percentage of our assets in UK related investments, to enable us to play a supportive role in the development of the UK economy,” said Catherine Cripps, member of the investment committee, Nuclear Liabilities Fund. “We believe that British Patient Capital can help us achieve our required returns whilst playing this role. We are delighted that British Patient Capital’s strategy is a natural fit to this approach.”

This mandate marks the first third-party source of funds for British Patient Capital and comes only 10 months since the business launched in June 2018.

Since June last year, British Patient Capital has grown its portfolio to 31 funds, which have backed more than 200 businesses to date.

Silicon Fen: Cambridge continues to attract tech firms

Brexit undoubtedly hangs over the market, but Cambridge (or as it sometimes referred to “Silicon Fen”) remains a magnet for science and technology companies

With its aim to address the funding gap at the scale-up stage, Catherine Lewis La Torre, CEO, British Patient Capital, commented: “This is an exciting next step in British Patient Capital’s journey. NLF’s investment is testament to British Patient Capital’s investment strategy and establishes our credentials as a professional fund manager of third-party capital.

“We’re delighted that the Nuclear Liabilities Fund shares our confidence in the potential for our investment strategy to deliver attractive commercial returns which will help them meet their future liabilities. We plan to continue to attract institutional capital to expand institutional investor diversity in the venture and growth asset class.”

Avatar photo

Andrew Ross

As a reporter with Information Age, Andrew Ross writes articles for technology leaders; helping them manage business critical issues both for today and in the future

Related Topics

Tech scaleups
Tech Startups